(Q81399451)
Statements
Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients (English)
Tomomi Toubai
Junji Tanaka
Shuichi Ota
Takashi Fukuhara
Satoshi Hashino
Takeshi Kondo
Masaharu Kasai
Yasutaka Kakinoki
Masanobu Morioka
Tsugumichi Kawamura
Hiroshi Iwasaki
Masahiro Asaka
Masahiro Imamura